FGFR3 GENE MUTATION
Clinical trials for FGFR3 GENE MUTATION explained in plain language.
Never miss a new study
Get alerted when new FGFR3 GENE MUTATION trials appear
Sign up with your email to follow new studies for FGFR3 GENE MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Targeted pill aims to shrink recurrent bladder tumors before surgery
Disease control OngoingThis study is testing whether a pill called erdafitinib can shrink recurrent bladder tumors in people with a specific genetic change (FGFR3 mutation). The drug is taken for a short period before a standard procedure to remove the tumor. Researchers want to see if this targeted ap…
Matched conditions: FGFR3 GENE MUTATION
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
New targeted drug trial aims to control advanced cancers with specific gene fault
Disease control OngoingThis study is testing an investigational drug called TYRA300 for people with advanced bladder cancer and other solid tumors that have specific changes in a gene called FGFR3. The main goals are to find a safe and effective dose and to see if the drug can shrink or control the tum…
Matched conditions: FGFR3 GENE MUTATION
Phase: PHASE1, PHASE2 • Sponsor: Tyra Biosciences, Inc • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC